DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...
Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
An expanded synthetic biology platform enables the assembly of long, high-complexity DNA sequences, reducing technical barriers and supporting next-generation research in medicine, vaccines, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results